about
[Relationship between lipid alterations during pregnancy and adverse pregnancy outcomes].Review and analysis of physical exercise at hormonal and brain level, and its influence on appetite.[Single coronary artery and right aortic arch].Obstructive sleep apnea syndrome: An important piece in the puzzle of cardiovascular risk factors.Statins and percutaneous coronary intervention: a complementary synergy.The postprandial situation as a pro-inflammatory condition.Effects of thyroid hormones on the heart.The pleiotropic role of HDL in autoimmune diseases.The application of atherogenic dyslipidaemia consensus recommendations in the primary care setting. DAT-AP study.HSP90 inhibitors as a future therapeutic strategy in diabetes-driven atherosclerosis.Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials.Familial hypercholesterolemia in childhood and adolescents: A hidden reality.Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicity.Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.Ceramide-enriched LDL induces cytokine release through TLR4 and CD14 in monocytes. Similarities with electronegative LDL.Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event.Exploring the effects of the atherosclerosis progression and the choice of affected arteries in the design of experiments with Apolipoprotein E-deficient mice.[A glow in the secondary prevention of cardiovascular disease].Effect on the lipid parameters of an intervention to reduce weight in overweight and obese patients.[PCSK9: Structure and function. PCSK9 and low-density lipoprotein receptor. Mutations and their effects].Necesidades no cubiertas: una visión de futuro.[Chronic kidney disease and dyslipidaemia].[Statin associated myopathy in clinical practice. Results of DAMA study].Serum uric acid as prognostic marker of coronary heart disease (CHD).[Dyslipidemia and atherogenic risk in patients with rheumatoid arthritis].[Epidemiology of diabetes mellitus in South America: The experience of Colombia].[Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].[Aerobic capacity, weight status and self-concept in schoolchildren].[Hyperglycaemia is associated with worse outcomes in Latin-American individuals with acute myocardial infarction].[Cancer and cardiovascular disease].[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice].[2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the InMTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.[In vitro study over statins effects on cellular growth curves and its reversibility with mevalonate].[Therapeutic Strategies. Cardiovascular risk and dyslipidemia in elderly and women].[Combined treatment: regimens, indications and safety profile].[Epidemiology of atherogenic dyslipidemia in an urban area of the city of Barcelona].[Introduction].Low-carbohydrate, high-protein, high-fat diet alters small peripheral artery reactivity in metabolic syndrome patients.
P1433
Q30252140-422F9D6D-6629-49ED-BEC8-CC5DF044C181Q30572874-05A569DC-0C0E-46E2-90EC-F033D6EB437BQ33164845-B6937D57-ED01-4C7F-A35C-9313662EAABEQ33359660-C285DAF2-CB09-497F-A76C-2301EA441196Q38147250-A8F74C41-DD5C-41E4-BE43-051E0D8355F3Q38215365-89F6DD9D-224A-4940-82F2-EB78B84EAF26Q38273462-443A1041-AAC0-4EB1-88E2-FBC1EA95C8B8Q38274713-F5865E76-5F3B-435F-A718-C3B32B07523DQ38709883-9236ECC9-D9F0-4D26-9394-50BE4141BEC5Q38748649-92C5AD3F-1174-4F02-89F0-BE9BFA575F62Q38821727-3EB549C0-9009-4073-971E-849BF8F06E6DQ38846416-6E418149-9B2A-415F-ADDB-7E406087282FQ38846417-A9DD25BE-FC0D-42CF-A531-66164A68AFBDQ38848306-CF4CA666-39F9-4BC3-BDD4-7B8EED0F47C0Q38969485-FD2B948A-AACB-441A-B2AE-215485F37FEEQ39015509-A163BA91-CC33-4C3B-AC8E-17CB9603FE5FQ39173583-AE6DDBA0-8DC7-4B61-A8DB-0970FF8EB0B1Q39980445-1EE9F14B-1B4B-4702-BD33-8C53506C334EQ40345806-3F1A65CC-45B1-44E6-85F0-544F4F9658CFQ40454083-08DB456B-AC0A-4F48-97FC-7FA096E88853Q40456575-E3A08DC1-B7AF-45BF-9B9E-DAD79B02F2AFQ40456585-9A836B5E-56AD-4231-A1E3-8207EFDDB92CQ40467768-30652D6A-CE2B-4358-A22D-3F3AD76DD664Q40549923-B6E785EE-A2B3-4752-9FC0-591DF8539054Q40567938-682209C8-1B40-4F04-8AFF-D159DFF53CC8Q40827950-F7C43532-4DDB-4FD9-9A04-68FC07B081BAQ40868783-16701DC1-263B-4D8D-83DD-4F43F7197544Q41060990-C4FB9741-B1AE-49CB-83D8-9766F27801C0Q41091690-998B0C18-2F7C-4262-8DD7-055AFBBF186DQ41105077-63928ED8-4A26-4F59-B21F-25CED5661B41Q43448959-F98B58F9-3680-4068-863C-756350799202Q43471317-17322229-2487-48D8-94CB-E5AAB2D0199DQ43580643-5EF4C191-6D92-4E73-8A51-2FDF60431E0BQ43984560-04586072-3333-4844-BE05-A85E845C94B3Q44210767-441210FF-DB3F-4FD4-9551-3DD928B179DCQ44283910-5D8ECBB3-D7C4-484C-8A98-D6E2DB3DA296Q44360841-99396BAE-D04D-4611-AB98-C2128A76701CQ44720586-07E4EA71-FDB9-4DA8-9356-AEADD95BD14AQ44850295-EC4DD950-D396-45D9-89B3-02029B782BC1Q44864546-BC2BC8CF-5777-4F88-926A-B282F8E0AEF2
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Clínica e Investigación en Arteriosclerosis
@en
Clínica e Investigación en Arteriosclerosis
@es
Clínica e Investigación en Arteriosclerosis
@fr
Clínica e Investigación en Arteriosclerosis
@pt
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@ast
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@nl
type
label
Clínica e Investigación en Arteriosclerosis
@en
Clínica e Investigación en Arteriosclerosis
@es
Clínica e Investigación en Arteriosclerosis
@fr
Clínica e Investigación en Arteriosclerosis
@pt
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@ast
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@nl
altLabel
Clin Investig Arterioscler
@en
prefLabel
Clínica e Investigación en Arteriosclerosis
@en
Clínica e Investigación en Arteriosclerosis
@es
Clínica e Investigación en Arteriosclerosis
@fr
Clínica e Investigación en Arteriosclerosis
@pt
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@ast
Clínica e Investigación en Arteriosclerosisde Arteriosclerosis
@nl
P31
P1055
P1156
7200153133
P123
P1476
Clínica e Investigación en Arteriosclerosis
@es
P236
P407
P5963
clinica-e-investigacion-en-arteriosclerosis